Periorbital cellulitis
Definition
Periorbital cellulitis is an infection of the eyelid or skin around the eye.
Alternative Names
Preseptal cellulitis
Causes
Periorbital cellulitis can occur at any age, but more commonly affects children younger than 5 years old.
This infection can occur after a scratch, injury, or bug bite around the eye, which allows germs to enter the wound. It can also extend from a nearby site that is infected, such as the sinuses.
Periorbital cellulitis is different than orbital cellulitis, which is an infection of the fat and muscles around the eye. In contrast to periorbital cellulitis, orbital cellulitis is a dangerous infection, which can cause lasting problems and deeper infections.
Symptoms
Symptoms include:
- Redness around the eye or in the white part of the eye
- Swelling of the eyelid, whites of eyes, and surrounding area
This condition usually does not affect vision or cause eye pain.
Exams and Tests
Your health care provider will examine the eye, especially, eye movements and test for vision, and ask about the symptoms.
Tests that may be ordered include:
Treatment
Antibiotics are given by mouth, by shots, or through a vein (intravenously; IV) to help fight the infection.
Outlook (Prognosis)
Periorbital cellulitis almost always improves with treatment. In rare cases, the infection spreads into the eye socket, resulting in orbital cellulitis.
When to Contact a Medical Professional
Contact your provider right away if:
- The eye becomes red or swollen
- Symptoms get worse after treatment
- Fever develops along with eye symptoms
- It is difficult or painful to move the eye
- The eye looks like it is sticking (bulging) out
- There are vision changes
References
Durand ML. Periocular infections. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 116.
Olitsky SE, Marsh JD, Jackson MA. Orbital infections. In: Kliegman RM, St. Geme JW, Blum NJ, ed. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 674.
|
Review Date:
12/31/2023
Reviewed By:
Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.
© 1997-
A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
© 1997-

All rights reserved.